Home > Boards > US Listed > Biotechs > Lexicon Genetics (LXRX)

News: $LXRX Lexicon Pharmaceuticals Enters Into Agreement With

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
whytestocks Member Profile
Member Level 
Followed By 107
Posts 14,757
Boards Moderated 2
Alias Born 06/04/18
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 11/17/2020 7:23:07 AM
Results From SOLOIST and SCORED Outcomes Studies Presented at Late-Breaking Science Session of American Heart Association Sci... GlobeNewswire Inc. - 11/16/2020 10:01:39 PM
Lexicon Pharmaceuticals to Participate in the Stifel 2020 Virtual Healthcare Conference GlobeNewswire Inc. - 11/16/2020 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/30/2020 5:11:39 PM
Lexicon Pharmaceuticals Reports Third Quarter 2020 Financial Results and Provides Clinical Update GlobeNewswire Inc. - 10/29/2020 6:00:10 AM
Lexicon Pharmaceuticals to Host Third Quarter 2020 Financial Results Conference Call and Webcast on October 29, 2020 GlobeNewswire Inc. - 10/27/2020 8:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/29/2020 7:14:42 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/24/2020 7:13:15 AM
Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding Indebtedness GlobeNewswire Inc. - 9/23/2020 6:43:26 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/11/2020 4:12:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/8/2020 5:03:21 PM
Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera Therapeutics GlobeNewswire Inc. - 9/8/2020 4:05:10 PM
Lexicon Pharmaceuticals Announces Commencement of Patient Dosing in RELIEF-DPN-1 Phase 2 Clinical Study of LX9211 in Patients... GlobeNewswire Inc. - 9/4/2020 8:00:10 AM
Lexicon Pharmaceuticals to Participate in the Citi 15ᵗʰ Annual BioPharma Virtual Conference and the Wells Fargo 2020 Virtu... GlobeNewswire Inc. - 9/3/2020 6:00:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/4/2020 6:00:51 AM
GTCR and TerSera Therapeutics Announce Acquisition of Xermelo PR Newswire (US) - 8/3/2020 7:25:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 7:19:01 AM
Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program GlobeNewswire Inc. - 7/30/2020 7:15:10 AM
Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO GlobeNewswire Inc. - 7/30/2020 7:10:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/30/2020 7:05:27 AM
Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business Update GlobeNewswire Inc. - 7/30/2020 7:00:10 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 7/29/2020 5:08:32 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 7/29/2020 4:57:55 PM
Lexicon Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call and Webcast on July 30, 2020 GlobeNewswire Inc. - 7/23/2020 7:00:10 AM
Lexicon Pharmaceuticals Announces Topline Phase 3 Data From Four Phase 3 Sotagliflozin Studies in Type 2 Diabetes GlobeNewswire Inc. - 7/21/2020 7:00:10 AM
whytestocks Member Level  Thursday, 07/30/20 09:00:07 PM
Re: None
Post # of 641 
News: $LXRX Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO

THE WOODLANDS, Texas and DEERFIELD, Ill., July 30, 2020 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) and TerSera Therapeutics LLC announced today that they have entered into an asset purchase and sale agreement for the sale to TerSera of Lexicon’s rights, titl...

Read the whole news LXRX - Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELO

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences